Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | inositol-1 | 0.0038 | 0.0077 | 0.0077 |
Trypanosoma brucei | inositol-1(or 4)-monophosphatase 1, putative | 0.0038 | 0.0077 | 1 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD7 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.0043 | 0.6416 |
Toxoplasma gondii | inositol(myo)-1(or 4)-monophosphatase 2, putative | 0.0038 | 0.0077 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1224 | 0.2999 | 0.3003 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0011 | 0.0009 | 0.318 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0043 | 0.5587 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.123 | 0.3014 | 1 |
Schistosoma mansoni | protein kinase | 0.4064 | 1 | 1 |
Schistosoma mansoni | protein kinase | 0.4064 | 1 | 1 |
Mycobacterium tuberculosis | Fatty-acid-AMP ligase FadD30 (fatty-acid-AMP synthetase) (fatty-acid-AMP synthase) | 0.0018 | 0.0028 | 0.412 |
Echinococcus granulosus | mitogen activated protein kinase kinase kinase | 0.4064 | 1 | 1 |
Leishmania major | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0038 | 0.0077 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0011 | 0.0009 | 0.1141 |
Mycobacterium ulcerans | long-chain-fatty-acid-CoA ligase | 0.0025 | 0.0043 | 0.5587 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0011 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0043 | 0.5587 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD3 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0017 | 0.0025 | 0.3749 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0018 | 0.0028 | 0.3588 |
Mycobacterium leprae | possible inositol monophosphatase SubH (IMPase) (inositol-1-phosphatase) (I-1-Pase ). | 0.0034 | 0.0067 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0011 | 0.0009 | 0.318 |
Plasmodium falciparum | acyl-CoA synthetase | 0.0018 | 0.0028 | 1 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0043 | 0.5587 |
Mycobacterium ulcerans | hypothetical protein | 0.0025 | 0.0043 | 0.5587 |
Loa Loa (eye worm) | hypothetical protein | 0.4058 | 0.9985 | 1 |
Mycobacterium ulcerans | long-chain-fatty-acid--CoA ligase | 0.0025 | 0.0043 | 0.5587 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0011 | 0.0009 | 0.318 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0011 | 0.0009 | 0.0009 |
Entamoeba histolytica | myo-inositol monophosphatase, putative | 0.0038 | 0.0077 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0011 | 0.0009 | 0.0009 |
Brugia malayi | brahma associated protein 60 kDa | 0.0011 | 0.0009 | 0.0009 |
Echinococcus multilocularis | inositol monophosphatase 1 | 0.0038 | 0.0077 | 0.0077 |
Schistosoma mansoni | hypothetical protein | 0.0176 | 0.0417 | 0.0417 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0011 | 0.0009 | 0.0009 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD2 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0025 | 0.0043 | 0.6416 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0011 | 0.0009 | 0.0009 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0011 | 0.0009 | 0.1141 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0038 | 0.0077 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0043 | 0.0043 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD7 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0017 | 0.0025 | 0.3749 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0043 | 0.0043 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0043 | 0.0043 |
Entamoeba histolytica | acyl-coA synthetase, putative | 0.0025 | 0.0043 | 0.5587 |
Schistosoma mansoni | brg-1 associated factor | 0.0011 | 0.0009 | 0.0009 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0011 | 0.0009 | 0.0009 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0043 | 0.5587 |
Echinococcus granulosus | inositol monophosphatase 1 | 0.0038 | 0.0077 | 0.0077 |
Mycobacterium leprae | PROBABLE FATTY-ACID-CoA LIGASE FADD2 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) | 0.0025 | 0.0043 | 0.6416 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0038 | 0.0077 | 0.0255 |
Trypanosoma cruzi | STE/STE11 serine/threonine-protein kinase, putative | 0.123 | 0.3014 | 1 |
Chlamydia trachomatis | acylglycerophosphoethanolamine acyltransferase | 0.0018 | 0.0028 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0028 | 0.0028 |
Mycobacterium tuberculosis | Probable chain -fatty-acid-CoA ligase FadD13 (fatty-acyl-CoA synthetase) | 0.0025 | 0.0043 | 0.6416 |
Mycobacterium ulcerans | acyl-CoA synthetase | 0.0025 | 0.0043 | 0.5587 |
Echinococcus multilocularis | geminin | 0.0176 | 0.0417 | 0.0417 |
Plasmodium vivax | acyl-CoA synthetase, putative | 0.0018 | 0.0028 | 1 |
Loa Loa (eye worm) | STE/STE11/ASK protein kinase | 0.123 | 0.3014 | 0.3018 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0011 | 0.0009 | 0.1141 |
Mycobacterium ulcerans | long-chain fatty-acid CoA ligase | 0.0025 | 0.0043 | 0.5587 |
Brugia malayi | AMP-binding enzyme family protein | 0.0025 | 0.0043 | 0.0043 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | brahma associated protein | 0.0011 | 0.0009 | 0.0009 |
Mycobacterium ulcerans | extragenic suppressor protein SuhB | 0.0038 | 0.0077 | 1 |
Trichomonas vaginalis | inositol monophosphatase, putative | 0.0038 | 0.0077 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0043 | 0.0043 |
Schistosoma mansoni | inositol monophosphatase | 0.0038 | 0.0077 | 0.0077 |
Brugia malayi | brahma associated protein 60 kDa | 0.0011 | 0.0009 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0028 | 0.0028 |
Loa Loa (eye worm) | hypothetical protein | 0.0025 | 0.0043 | 0.0043 |
Echinococcus multilocularis | mitogen activated protein kinase kinase kinase | 0.4064 | 1 | 1 |
Brugia malayi | Inositol-1 | 0.0038 | 0.0077 | 0.0077 |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD5 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0017 | 0.0025 | 0.3749 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.0043 | 0.5587 |
Echinococcus granulosus | geminin | 0.0176 | 0.0417 | 0.0417 |
Entamoeba histolytica | acyl-CoA synthetase, putative | 0.0025 | 0.0043 | 0.5587 |
Trichomonas vaginalis | myo inositol monophosphatase, putative | 0.0038 | 0.0077 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0028 | 0.0028 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0011 | 0.0009 | 0.0009 |
Leishmania major | 4-coumarate:coa ligase-like protein | 0.0025 | 0.0043 | 0.5587 |
Mycobacterium ulcerans | fatty-acid-CoA ligase | 0.0025 | 0.0043 | 0.5587 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0011 | 0.0009 | 0.0009 |
Trypanosoma cruzi | myo-inositol-1(or 4)-monophosphatase 1, putative | 0.0038 | 0.0077 | 0.0255 |
Schistosoma mansoni | hypothetical protein | 0.0011 | 0.0009 | 0.0009 |
Onchocerca volvulus | 0.0025 | 0.0043 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0018 | 0.0028 | 0.0028 |
Schistosoma mansoni | hypothetical protein | 0.0011 | 0.0009 | 0.0009 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0011 | 0.0009 | 0.318 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0011 | 0.0009 | 0.0009 |
Schistosoma mansoni | hypothetical protein | 0.0176 | 0.0417 | 0.0417 |
Schistosoma mansoni | inositol monophosphatase | 0.0038 | 0.0077 | 0.0077 |
Wolbachia endosymbiont of Brugia malayi | fructose-1,6-bisphosphatase | 0.0038 | 0.0077 | 0.5 |
Onchocerca volvulus | 0.0011 | 0.0009 | 0.2042 | |
Mycobacterium tuberculosis | Probable fatty-acid-CoA ligase FadD35 (fatty-acid-CoA synthetase) (fatty-acid-CoA synthase) | 0.0017 | 0.0025 | 0.3749 |
Mycobacterium tuberculosis | Inositol-1-monophosphatase SuhB | 0.0034 | 0.0067 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MDA-N Breast cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the DU-145 Prostate cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the MALME-3M Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.